Summer 2026 Prime Therapeutics Report
Specialty insights to watch
The Summer 2026 Prime Therapeutics Report delivers practical insights on the therapies, trends and market developments shaping specialty management today.
Inside this issue:
Autoimmune update: Expanding biosimilar landscape and payer impact
IntegratedRx® update: Oncology and cystic fibrosis solutions
Managed care newsstand: Policy and industry developments affecting PBM economics, contracting and operations
COPD and ophthalmology: Treatment landscape updates and payer management considerations
Pipeline: Upcoming decision dates and potential trend drivers
Whether you’re a managed care executive, clinician or pharmacy leader, this report offers practical insights to help evaluate emerging therapies, prepare for market changes and support informed coverage, access and management decisions.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
Login Portals
Compliance / Legal
Company
